Evidence map›Paper›PMID 39308069›Full record

ArticleJournal of Zhejiang University. Science. B2024

Early senescence of pancreatic β cells induced by unfolded protein response deficiency prevents type 1 diabetes.

Haipeng Cheng, Zhenwang Zhao, Dan Liu, Yufei Wang, Min Zhang

Abstract read
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haipeng ChengDepartment of Pathology, the Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zhenwang ZhaoSchool of Basic Medicine, Health Science Center, Hubei University of Arts and Science, Xiangyang 441053, China.
Dan LiuMedical Education Department, Guangdong Provincial People's Hospital, Zhuhai Hospital (Jinwan Central Hospital of Zhuhai), Zhuhai 519041, China.
Yufei WangSchool of Basic Medicine, Health Science Center, Hubei University of Arts and Science, Xiangyang 441053, China. mzhangusc@126.com, 11883@hbuas.edu.cn.
Min ZhangInstitute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Department of Bioinformatics and Medical Big Data, Hengyang Medical School, University of South China, Hengyang 421001, China. mzhangusc@126.com.

Funding

the Hubei Provincial Natural Science Foundation of China 2023AFB043the Hunan Provincial Natural Science Foundation of China 2022JJ40678the National Natural Science Foundation of China 82200086 and 82300522the Open Project Program of Guangxi Key Laboratory of Centre of Diabetic Systems Medicine, Guilin Medical University GKLCDSM-20210101-04
6 · The paper itself

Abstract

Type 1 diabetes (T1D) is a T lymphocyte-mediated autoimmune disease caused by pancreatic β‍-cell destruction, which eventually leads to reduced insulin level and increased blood glucose level (Syed, 2022). As a multifactorial disease, T1D is characterized by a genetic predisposition associated with various environmental and cellular elements (Syed, 2022). Pancreatic β cells have long been considered the "innocent victims" in T1D pathogenesis since the pancreas is attacked by the immune cells, resulting in a process known as insulitis, in which the immune cells infiltrate pancreatic islets and secrete pro-inflammatory cytokines. However, growing evidence suggests that various β‍-cell stresses, dysfunction, and death contribute to T1D pathogenesis, as it has been observed that β‍-cell dysfunction in autoantibody-positive (Aab

Indexed as

Cellular SenescenceDiabetes Mellitus, Type 1Insulin-Secreting CellsUnfolded Protein ResponseAnimalsAutoantibodiesHumansMiceAutoantibodies

Identifiers

PMID39308069
PMCPMC11422799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.